Mitzi Nagarkatti to Antineoplastic Agents
This is a "connection" page, showing publications Mitzi Nagarkatti has written about Antineoplastic Agents.
Connection Strength
0.667
-
Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma. PLoS One. 2012; 7(4):e35650.
Score: 0.231
-
Grincamycins P-T: Rearranged Angucyclines from the Marine Sediment-Derived Streptomyces sp. CNZ-748 Inhibit Cell Lines of the Rare Cancer Pseudomyxoma Peritonei. J Nat Prod. 2021 05 28; 84(5):1638-1648.
Score: 0.108
-
Safety of natural anthraquinone emodin: an assessment in mice. BMC Pharmacol Toxicol. 2021 01 28; 22(1):9.
Score: 0.106
-
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis. Immunobiology. 2013 Apr; 218(4):674-82.
Score: 0.059
-
Bryostatin-1, a naturally occurring antineoplastic agent, acts as a Toll-like receptor 4 (TLR-4) ligand and induces unique cytokines and chemokines in dendritic cells. J Biol Chem. 2011 Jan 07; 286(1):24-34.
Score: 0.052
-
Calcium ionophores at concentrations mitogenic to normal murine T cells inhibit the proliferation of tumor cells in vitro. Cancer Commun. 1989; 1(5):329-34.
Score: 0.046
-
Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells. Leuk Res. 2005 Aug; 29(8):915-22.
Score: 0.035
-
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002 Jul 15; 100(2):627-34.
Score: 0.029